Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.3) and removes the previous revision (v3.6.1), indicating an update to the page's version history.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study record history now includes a new revision entry (v3.6.1), updating the version history. This replaces the previous v3.6.0 entry.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.5.5 was added to the history and the previous v3.5.4 entry was removed. This reflects an update to the page's revision record.SummaryDifference0.1%

- Check49 days agoChange DetectedThe Record History now includes a new revision entry, v3.5.4, replacing the previous v3.5.3. This reflects a small update to the page's revision metadata rather than any change to the study content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe Record History now lists Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the history.SummaryDifference0.1%

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.